Atlas Trials

The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

Clinical trial NCT03236636 · UNKNOWN

Trial details

NCT number
NCT03236636
Sponsor
Beijing Shenogen Biomedical Co., Ltd
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced HBV-Related Hepatocellular Carcinoma (HCC)
Start date
2017-09-08
Primary completion
2022-12-30
Enrollment
312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.